Under basal conditions, suppressed NMNAT1 expression levels among lung cancer cell lines have not been accompanied by proportional reductions in NAD+ levels, implying that the other two NMNAT isoforms are arguably the main drivers of total cellular NAD+ levels [108]. The gene discussed is NMNAT1; the disease is lung cancer.